Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06547008 · ClinicalTrials.gov registry record · Phase 1
Army-SPRING Army-Suicide Prevention Research
A Phase 1 study of Suicide, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 57
- Enrollment target
- 3
- Study locations
NCT06547008: Recruiting Phase 1 study of Suicide, sponsored by University of Pennsylvania.
NCT06547008 is a Phase 1 study of Suicide that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 57 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06547008, a Phase 1 study of Suicide, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 57 participants
- Enrollment target
- 3
- Study locations
Study Summary
Every unit in the Connecticut Army National Guard has a Suicide Intervention Officer to provide suicide intervention education awareness for their unit, monitor for soldiers in crisis and connect soldiers with helping resources and agencies. Suicide Intervention Officers need support in this difficult role, yet there is limited guidance on how to help them. This study will shed light on how to support Suicide Intervention Officers and whether this support results in reduced suicide risk in their units.
Primary Outcome
Use of suicide prevention services for self, URI-3 item 75
Conditions Studied
Interventions
- BEHAVIORAL Army-SPRING
- BEHAVIORAL Risk Reduction Group (Control)
Study Locations (3)
Connecticut
- Connecticut Army National Guard - Hartford
- Yale University - New Haven
Pennsylvania
- Center for the Treatment and Study of Anxiety, University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2025-03-19 |
| Est. Completion | 2028-08 |
| Phase | Phase 1 |
What NCT06547008 shows while recruiting
NCT06547008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Army-SPRING is the first listed.
NCT06547008 reports a single indexed study location in Connecticut, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06547008 about?
NCT06547008 is a clinical study titled "Army-SPRING Army-Suicide Prevention Research". Every unit in the Connecticut Army National Guard has a Suicide Intervention Officer to provide suicide intervention education awareness for their unit, monitor for soldiers in crisis and connect soldiers with helping resources and agencies. Suicide Intervention Officers need support in this difficu...
What is the current status of trial NCT06547008?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 57 participants. The study started on 2025-03-19. Estimated completion is 2028-08.
What conditions does trial NCT06547008 study?
This clinical trial studies the following conditions: Suicide.
What interventions are being tested in trial NCT06547008?
The interventions under investigation include: Army-SPRING (BEHAVIORAL), Risk Reduction Group (Control) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06547008?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06547008 being conducted?
This trial has 3 study locations across Connecticut, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06547008's enrollment target sits among peer trials
57 69th of 92 higher than 23 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
RECRUITING · Phase 1
-
Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)
COMPLETED · Phase 1
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI